CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioRegenx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioRegenx Inc
5051 Peachtree Corners Circle
Number 200, Suite 400
Phone: (404) 443-3224p:404 443-3224 NORCROSS, GA  30092  United States Ticker: FDITFDIT

This company ceased filing statements with the SEC on 12/28/2010.

Business Summary
BioRegenx, Inc., formerly Findit, Inc., operates as a holding company. The Company specializes in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. Its primary focus involves acquiring and developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing datasets. The Company’s patented technologies and solutions include GlycoCheck, a high-definition video imaging that analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology; Endocalyx Pro, an all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies, and DocSun, an artificial intelligence using three advanced facial recognition technologies that analyzes 21 vital signs and health indicators without physical contact.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Director DarrellFigg 3/8/2024 7/8/2004
Chief Executive Officer, Interim Chief Financial Officer, Director WilliamResides 55 3/8/2024
Chief Operating Officer, Director SherriAdams 3/8/2024 3/8/2024
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Austin Chalk Oil and Gas Ltd.
Austin Chalk Oil and Gas, Ltd.
FDIT
7 additional Business Names available in full report.

General Information
Number of Employees: 10 (As of 12/31/2023)
Outstanding Shares: 956,630,100 (As of 4/11/2024)
Shareholders: 298
Stock Exchange: OTC
Federal Tax Id: 912014670
Fax Number: (702) 866-2689
Email Address: info@sharewellcapital.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024